Your browser doesn't support javascript.
loading
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.
Bücklein, Veit; Perez, Ariel; Rejeski, Kai; Iacoboni, Gloria; Jurinovic, Vindi; Holtick, Udo; Penack, Olaf; Kharboutli, Soraya; Blumenberg, Viktoria; Ackermann, Josephine; Frölich, Lisa; Johnson, Grace; Patel, Kedar; Arciola, Brian; Mhaskar, Rahul; Wood, Anthony; Schmidt, Christian; Albanyan, Omar; Gödel, Philipp; Hoster, Eva; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; von Bergwelt, Michael; Barba, Pere; Subklewe, Marion; Jain, Michael D.
Afiliación
  • Bücklein V; Department of Medicine III, University Hospital, LMU Munich, Germany.
  • Perez A; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.
  • Rejeski K; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
  • Iacoboni G; Blood and Marrow Transplant Program, Miami Cancer Institute, Miami, FL, USA.
  • Jurinovic V; Department of Medicine III, University Hospital, LMU Munich, Germany.
  • Holtick U; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.
  • Penack O; German Cancer Consortium (DKTK) Munich Site, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kharboutli S; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Department of Medicine, Universitat Autònoma of Barcelona (UAB), Spain.
  • Blumenberg V; Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich, Germany.
  • Ackermann J; Department I of Internal Medicine, Medical Faculty and University Hospital, Cologne, University of Cologne, Germany.
  • Frölich L; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.
  • Johnson G; Department of Internal Medicine 5, Hematology and Oncology, University of Erlangen-Nuremberg, Germany.
  • Patel K; Department of Medicine III, University Hospital, LMU Munich, Germany.
  • Arciola B; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.
  • Mhaskar R; German Cancer Consortium (DKTK) Munich Site, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wood A; Department of Medicine III, University Hospital, LMU Munich, Germany.
  • Schmidt C; Department of Medicine III, University Hospital, LMU Munich, Germany.
  • Albanyan O; USF Health Morsani College of Medicine, Tampa, FL, USA.
  • Gödel P; USF Health Morsani College of Medicine, Tampa, FL, USA.
  • Hoster E; USF Health Morsani College of Medicine, Tampa, FL, USA.
  • Bullinger L; USF Health Morsani College of Medicine, Tampa, FL, USA.
  • Mackensen A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
  • Locke F; Department of Medicine III, University Hospital, LMU Munich, Germany.
  • von Bergwelt M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
  • Barba P; Department I of Internal Medicine, Medical Faculty and University Hospital, Cologne, University of Cologne, Germany.
  • Subklewe M; Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich, Germany.
  • Jain MD; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.
Hemasphere ; 7(8): e907, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37449196

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hemasphere Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hemasphere Año: 2023 Tipo del documento: Article País de afiliación: Alemania